Company / Working Capital per Share
Ernexa Therapeutics Inc. Working Capital per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.01
FY2025
5-year range
-$0.22 / $0.59
FY2021-FY2025
Trend
+105.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $-0.22 in FY2020 to $2.17 in FY2016.
Based on SEC 10-K filings.
0.01 in FY2025 with a 10-year CAGR of -18.1%.
Declined from $0.59 to $0.01 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -18.1%
Key checks
Key Insights
- In FY2025, working capital per share increased 105.4% year-over-year.
- Peak working capital per share was recorded in FY2016.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +105.4% |
| FY2024 | -$0.11 | -118.4% |
| FY2023 | $0.59 | +369.2% |
| FY2020 | -$0.22 | -2421.2% |
| FY2019 | -$0.01 | -100.8% |
| FY2018 | $1.10 | +9228.9% |
| FY2017 | -$0.01 | -100.6% |
| FY2016 | $2.17 | +4934.5% |
| FY2015 | $0.04 | -56.3% |
| FY2014 | $0.10 | +63.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026